Okey Stephanie sold CRNX

June 17, 2026 · Form 4 insider transaction

Okey Stephanie sold 6,292 shares of Crinetics Pharmaceuticals, Inc. at $35.62 per share, a transaction worth $224.1K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Disposed (sell-side)
Shares
6,292
Price
$35.62
Total value
$224.1K
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJune 17, 2026
Filing dateJune 18, 2026
Shares owned after7,008
OwnershipDirect
10b5-1 planYes
AmendedNo

Footnotes

The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 19, 2025.; The common stock was sold by the Reporting Person in open market transactions on the transaction date, with a volume weighted average sale price of $35.62 per share. The range of sale prices on the transaction date was $35.19 to $36.06. Detailed information on the exact number of shares can be obtained from the Issuer upon request.

View the original Form 4 on SEC EDGAR